Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone in Chronic Idiopathic Constipation: Phase 3 Double-blind Placebo-controlled Trial
jRCT2080220730Phase 3
- Sponsor
- Sucampo
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Lubiprostone 24 mcg BID with Placebo (2 arms).
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on jRCT2080220730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220730.